The Cardiovascular teams at Medpace are highly skilled in the scientific methodology, standard of care, evolving regulatory requirements and operational considerations that are necessary to bring drugs and devices that treat or prevent heart disease to market. Our extensive experience in cardiovascular studies paired with our proven track record of success in the cardiovascular CRO industry ensures the flexibility to adapt to the unique needs of each cardiovascular trial.
In order to ensure success, we help our clients:
Effectively plan and conduct cardiovascular studies for drug/device and cardiac safety
Efficiently conduct large cardiovascular endpoint trials that demand rigorous safety requirements
Seamlessly integrate cardiovascular trials with metabolic/endocrinology projects
Deep and Broad Cardiovascular Experience
Since inception in 1992, we have conducted hundreds of Phase I-IV cardiovascular trials for drugs and medical devices.
Through these studies, we have:
Involved patients in nearly 50 different countries
Contributed to countless cardiovascular NDAs
Pioneered many of the preventative cardiovascular drugs and devices introduced in the past 15 years
Important Cookie Information – This message will only appear once.